Home
About
Available Technologies
Services
PRIVACY POLICY
TW
BioMed Commercialization Center (BMCC), Taiwan
Welcome to BMCC, Taiwan
(BioMed Commercialization Center, Drug Division)
Contact Us
Available Technologies
More
Synthetic Peptide of Tumor Associated Antigen L6-based Cancer Immunotherapy
Synthetic Peptide of Tumor Associated Antigen L6-based Cancer Immunotherapy
Synthetic Peptide of Tumor Associated Antigen L6-based Cancer Immunotherapy
The Second Generation of αIIbβ3 Antagonist Prevent Thrombosis without the Risk of Bleeding
The Second Generation of αIIbβ3 Antagonist Prevent Thrombosis without the Risk of Bleeding
The Second Generation of αIIbβ3 Antagonist Prevent Thrombosis without the Risk of Bleeding
Treatment of Cancers with Refolding Human Serum Albumin
Treatment of Cancers with Refolding Human Serum Albumin
Treatment of Cancers with Refolding Human Serum Albumin
Quantity and Quality Controlled Bioprocess of Chimeric Antigen Receptor (CAR)-T Cells
Quantity and Quality Controlled Bioprocess of Chimeric Antigen Receptor (CAR)-T Cells
Quantity and Quality Controlled Bioprocess of Chimeric Antigen Receptor (CAR)-T Cells
3D Digital Pathology with MetaLite Software and AI-enabled analysis for Precision Diagnosis
3D Digital Pathology with MetaLite Software and AI-enabled analysis for Precision Diagnosis
JelloX Biotech Inc. retrieves 3D digital pathology big data from clinical specimen including solid tumor tissues and regenerativ...
Services
IP Analysis
IP Analysis
Read more
Tech Feasibility and Analysis
Tech Feasibility and Analysis
Read more
Market Analysis
Market Analysis
Read more
Tech Commercialization
Tech Commercialization
Read more
